A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012.

Andreea FarcasTeodora BalcescuLaura AnghelCamelia BucșaCristina Mogoșan

Published in: Expert opinion on drug safety (2020)

PRAC recommended routine or additional RMMs for most referrals. Complete withdrawal of a drug or withdrawal of certain pharmaceutical forms or concentrations was advised only when the risk could not be managed by RMMs.

Keyphrases

primary care
clinical practice
minimally invasive
drug induced
adverse drug
breast cancer risk